Treatment adherence with the easypod™ growth hormone electronic auto-injector and patient acceptance: survey results from 824 children and their parents
2011

Survey on Treatment Adherence with the Easypod™ Auto-Injector in Children

Sample size: 824 publication 10 minutes Evidence: moderate

Author Information

Author(s): Bozzola Mauro, Colle Michel, Halldin-Stenlid Maria, Larroque Sylvain, Zignani Monia

Primary Institution: Paediatric Department, University of Pavia, IRCCS San Matteo Foundation, Pavia, Italy

Hypothesis

Does the easypod™ auto-injector improve adherence to r-hGH treatment in children?

Conclusion

The easypod™ auto-injector shows good adherence to r-hGH treatment among children, especially those new to treatment.

Supporting Evidence

  • 87.5% of children were adherent to treatment over the 3-month period.
  • Recorded adherence was higher in treatment-naïve children (89.7%) than in treatment-experienced children (81.7%).
  • Over 90% of children/parents wanted to continue using the easypod™.

Takeaway

Most kids using the easypod™ for their growth hormone shots remembered to take their medicine, and they liked using the device.

Methodology

A multicentre, multinational, observational survey over 3 months where children used the easypod™ and reported their adherence.

Potential Biases

Potential bias in self-reported adherence data compared to recorded data.

Limitations

The study only followed participants for 3 months and relied on self-reported data for some adherence measures.

Participant Demographics

Children aged 1-18 years, with 56.1% boys and a mix of treatment-naïve and treatment-experienced participants.

Statistical Information

P-Value

0.0062

Statistical Significance

p = 0.0062

Digital Object Identifier (DOI)

10.1186/1472-6823-11-4

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication